Figure 7 showed that a representative patient with a TMIT-I type exhibited a hypermetabolic and heterogeneous tumor on 18F-FDG PET, characterized by high expression of PD-L1 and high density of PD-1, CD8+ TILs. This evidence concerns the gene CD274 and neoplasm.